dr. van zee on estimating risk for surgical options in dcis
Published 8 years ago • 1.9K plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
1:28
dr. van zee on nomograms for patients with dcis
-
2:19
kimberly j. van zee on nomograms helping in dcis treatment decision making
-
1:06
kimberly j. van zee on difficult decisions with a dcis diagnosis
-
0:57
dr. van zee discusses prevention of invasive recurrence in breast
-
5:39
ductal carcinoma in situ: anastrozole versus tamoxifen
-
8:22
what is dcis and what happens if we don't treat it? - with dr tasha
-
0:57
predictive biomarkers of recurrence may not be useful for de-escalating treatment in dcis
-
1:07
testing for dcis (ductal carcinoma in situ)
-
1:14
dr. silverstein discusses radiation therapy as treatment for dcis
-
52:08
emerging strategies in breast cancer care before, during and after surgery
-
1:59
dr. rakovitch on predicting risk of recurrence for women with dcis
-
5:26
improving risk prediction and decision making in dcis patients
-
0:55
dr. solin on personalizing treatment with the dcis score
-
1:00
dr. eleftherios mamounas on predicting the risk of dcis recurrence
-
10:42
deescalating dcis experts discuss new data from sabcs
-
1:01
dr. esserman on screening patients with higher-risk dcis
-
26:25
treatment decision making for dcis - dr. monica morrow
-
6:51
recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer
-
14:29
multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ